Volume 93, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Delayed hemolysis after parenteral artesunate has been described in Europe and Asia, but until recently had not been reported in patients receiving the artesunate product used in the United States and Canada. We report two cases of severe delayed hemolysis after the treatment with intravenous artesunate in Canada.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Dondorp A, Nosten F, Stepniewska K, Day N, White N, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) Group, , 2005. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366: 717725. [Google Scholar]
  2. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ, AQUAMAT Group; , 2010. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376: 16471657. [Google Scholar]
  3. World Health Organization, 2015. Guidelines for the Treatment of Malaria. Geneva, Switzerland: World Health Organization, 318.Available at: http://www.who.int/malaria/publications/atoz/9789241549127/en/. [Google Scholar]
  4. Rolling T, Schmiedel S, Wichmann D, Wittkopf D, Burchard GD, Cramer JP, , 2012. Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia. Malar J 11: 169. [Google Scholar]
  5. Caramello P, Balbiano R, De Blasi T, Chiriotto M, Deagostini M, Calleri G, , 2012. Severe malaria, artesunate and haemolysis. J Antimicrob Chemother 67: 20532054. [Google Scholar]
  6. Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, Bierman WF, Clerinx J, van Veldhuizen CK, de Vries PJ, , 2012. Treatment outcome of intravenous artesunate in patients with severe malaria in The Netherlands and Belgium. Malar J 11: 102. [Google Scholar]
  7. Kano S, , 2010. Artemisinin-based combination therapies and their introduction in Japan. J Infect Chemother 16: 375382. [Google Scholar]
  8. Zoller T, Junghanss T, Kapaun A, Gjorup I, Richter J, Hugo-Persson M, Morch K, Foroutan B, Suttorp N, Yurek S, Flick H, , 2011. Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis 17: 771777. [Google Scholar]
  9. Rehman K, Lotsch F, Kremsner PG, Ramharter M, , 2014. Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence. Int J Infect Dis 29: 268273. [Google Scholar]
  10. Raffray L, Receveur MC, Beguet M, Lauroua P, Pistone T, Malvy D, , 2014. Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report. Malar J 13: 398. [Google Scholar]
  11. Rolling T, Agbenyega T, Issifou S, Adegnika AA, Sylverken J, Spahlinger D, Ansong D, Lohr SJ, Burchard GD, May J, Mordmuller B, Krishna S, Kremsner PG, Cramer JP, , 2014. Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria—a double-center prospective study. J Infect Dis 209: 19211928. [Google Scholar]
  12. Rolling T, Wichmann D, Schmiedel S, Burchard GD, Kluge S, Cramer JP, , 2013. Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis. Malar J 12: 241. [Google Scholar]
  13. Centers for Disease Control and Prevention (CDC), 2013. Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria—worldwide, 2010–2012. MMWR 62: 58. [Google Scholar]
  14. Paczkowski MM, Landman KL, Arguin PM, Centers for Disease Control and Prevention (CDC); , 2014. Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria—United States, 2008 and 2013. MMWR 63: 753755. [Google Scholar]
  15. Lee J, Krajden S, Graham C, Boggild AK, Pavenski K, Keystone JS, Kain KC, , 2015. Severe delayed hemolysis associated with regulated parenteral antimalarial drug. Emerg Infect Dis 21: 164166. [Google Scholar]
  16. Shokoples SE, Ndao M, Kowalewska-Grochowska K, Yanow SK, , 2009. Multiplexed real-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections. J Clin Microbiol 47: 975980. [Google Scholar]
  17. Committee to Advise on Tropical Medicine and Travel (CATMAT), 2014. Canadian Recommendations for the Prevention and Treatment of Malaria. Ottawa, Canada: Public Health Agency of Canada, 135. Available at: http://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-102-2014-eng.pdf. [Google Scholar]
  18. Haldar K, Mohandas N, , 2009. Malaria, erythrocytic infection, and anemia. Hematology Am Soc Hematol Educ Program 2009: 8793. [Google Scholar]
  19. Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, ter Kuile F, Chongsuphajaisiddhi T, White NJ, , 2001. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg 65: 614622. [Google Scholar]
  20. Jaureguiberry S, Ndour PA, Roussel C, Ader F, Safeukui I, Nguyen M, Biligui S, Ciceron L, Mouri O, Kendjo E, Bricaire F, Vray M, Angoulvant A, Mayaux J, Haldar K, Mazier D, Danis M, Caumes E, Thellier M, Buffet P, French Artesunate Working Group; , 2014. Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins. Blood 124: 167175. [Google Scholar]
  21. Gu HM, Warhurst DC, Peters W, , 1986. Hemolysis induced by artemisinin and its derivatives in vitro. Zhongguo Yao Li Xue Bao 7: 269272. [Google Scholar]
  22. De Nardo P, Oliva A, Giancola ML, Ghirga P, Mencarini P, Bibas M, Nicastri E, Antinori A, Corpolongo A, , 2013. Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria. Infection 41: 863865. [Google Scholar]

Data & Media loading...

  • Received : 07 Apr 2015
  • Accepted : 03 Jun 2015
  • Published online : 07 Oct 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error